This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
Eligibility
Sex
ALL
Min age
6 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria:
* diagnosis of DSM5 ASD made by child and adolescent psychiatrist
* age 6-17 years-old at the time of enrolment
* no pharmacotherapy or non-pharmacotherapy adjustment within the past 4 weeks,
* Signed informed consent.
Exclusion Criteria:
* comorbid other psychiatric disorders, including schizophrenia or affective mood disorder (Bipolar and Major Depressive Disorder), or substance use disorder
* comorbid physical disorders, such as thyroid dysfunction, cerebral palsy, coagulation disorders
* currently using omega-3 supplements or probiotics
* allergy to omega-3.
Primary outcome measure(s)
Clinical Symptoms-Behavioral problems (Aberrant Behavior Checklist, ABC) — Baseline, week 1,2,4,8,12 The ABC will be used to assess the behavioral problems of participants. It consists of 58 items that describe various behaviors, such as aggression or hyperactivity, and is typically completed by a caregiver or teacher who knows the individual well. Each item is rated on a 4-point scale: 0 = not at all a problem, 1 = slight problem, 2 = moderate problem, and 3 = severe problem. Scores are summed across all items to produce a total score ranging from 0 to 174, with higher scores indicating more severe or frequent problem behaviors
Trial sites (1)
Facility
City
Region
Status
China Medical University
Taichung
Taichung
Recruiting
More China Medical University Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.